The Forgotten Pump - Waitlist & Post-Transplant Outcomes of Heart Transplant Recipients Supported by Heartware HVAD Before & After Device Recall

Purpose: In June 2021, the FDA issued a recall of the Heartware HVAD device prompting changes to the 2018 UNOS allocation policy. In July 2022, UNOS allowed patients with HVAD to be listed as Status 1,2, or 3 using the exception pathway and did not require hospitalization for higher status. What impact these changes had on waitlist and post-transplant outcomes for HVAD patients has yet to be reported.
Source: The Journal of Heart and Lung Transplantation - Category: Transplant Surgery Authors: Source Type: research